Research
Hormonal
Incretin-based therapy reduced all-cause mortality by 18%.
Incretin-based therapies may improve survival rates in overweight or obese individuals.
StrongSupportsmedium confidence
All-cause mortality was reduced by 18% (RR 0.82, 95% CI 0.76-0.90).
Why this rating
Based on a systematic review and meta-analysis of 85 RCTs.
Source
Effect of incretin-based therapies on blood pressure: a systematic review and meta-analysis
Christian Basile et al. · European Journal of Preventive Cardiology · 2025
Meta-analysisCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →